Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | AZN | AMGN | GILD | BMY |
| Company | Anika Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 15.00 | 197.38 | 375.00 | 146.55 | 60.34 |
| High | 15.00 | 197.38 | 375.00 | 146.55 | 60.34 |
| Low | 15.00 | 197.38 | 375.00 | 146.55 | 60.34 |
| Latest | 14.73 | 196.75 | 374.62 | 148.38 | 60.33 |
| Change | -0.23 | +1.80 | -2.35 | +1.75 | -0.30 |
| % Change | -1.54% | +0.92% | -0.62% | +1.19% | -0.49% |
| Volume | 620 | 13,766 | 3,858 | 4,415 | 4,924 |
| 20-Day Average Volume | 143,726 | 2,127,183 | 2,548,913 | 7,101,686 | 12,273,456 |
| Previous Close | 14.96 | 194.95 | 376.97 | 146.63 | 60.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.22 | 203.00 | 375.76 | 149.30 | 60.90 |
| 20-Day Raw Stochastic | 99.81% | 34.37% | 46.22% | 26.03% | 30.36% |
| 20-Day Relative Strength | 82.39 | 51.30 | 55.89 | 54.48 | 55.81 |
| Weighted Alpha | +13.01 | +33.38 | +28.03 | +38.33 | +14.84 |
| Today's Opinion | 100% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 48% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.17% since 03/03/26 | -2.17% since 03/03/26 | -0.53% since 03/03/26 | -0.87% since 03/03/26 | -1.44% since 03/03/26 |
| Low | 13.81 on 03/06/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 15.01 on 03/09/26 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | +45.21% since 02/10/26 | +2.06% since 02/10/26 | +2.84% since 02/10/26 | -0.46% since 02/10/26 | -0.85% since 02/10/26 |
| Low | 9.88 on 02/13/26 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 15.01 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +55.60% since 12/10/25 | +7.85% since 12/10/25 | +18.90% since 12/10/25 | +20.78% since 12/10/25 | +17.83% since 12/10/25 |
| Low | 9.01 on 01/28/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.44 on 12/11/25 |
| High | 15.01 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +78.57% since 09/10/25 | +22.13% since 09/10/25 | +34.65% since 09/10/25 | +27.16% since 09/10/25 | +27.97% since 09/10/25 |
| Low | 8.44 on 09/11/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 15.01 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 200,479 | 302,349,504 | 203,212,464 | 182,029,584 | 123,471,424 |
| Shares Outstanding, K | 13,401 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 112,820,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -10,880,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 30,620,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 290,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.33 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.04 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/08/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 9.80 |